SynAgile
Piedmont
About SynAgile
SynAgile™ is dedicated to transforming the treatment of L-DOPA-responsive motor and non-motor complications in patients with Parkinson's disease. Our novel drugs and routes of administration are designed to enable patients to achieve stable plasma L-DOPA concentrations, and to provide convenient, continuous dopaminergic stimulation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $11.3M
- Last round: Equity Crowdfunding (Aug 2017)
- Website: synagile.com
- Phone: 510-908-3496
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/synagile-158954 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.